Effects of a-fluoromethylhistidine on sleep and wakefulness in the rat
Authors:
- 1 June 1988
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 72 (2) , 141-145
Abstract
The histamine synthesis inhibitor a-fluoromethylhistidine (a-FMH, 50mg/kg, i.p.) significantly reduced wakefulness (W) and light sleep and increased slow wave sleep (SWS) and REM sleep during the light period in rats housed under 12 h light/12 h dark conditions (12L/12D). When animals were housed under 16 h light/8 h dark (16L/8D) they remained awake for a longer period of time during the dark as compared to the 12L/ 12D lighting cycle. Under this condition a-FMH 50mg/kg significantly decreased W and increased SWS. Our results tend to indicate that histamine intervenes in sleep-wakefulness regulation. In addition, histamine could be partly involved in the abnormally increased incidence of W observed during the dark in rats housed under 16L/ 8D conditions.Keywords
This publication has 8 references indexed in Scilit:
- Effects of H1- and H2-histamine receptor agonists and antagonists on sleep and wakefulness in the ratJournal of Neural Transmission, 1986
- [Role of hypothalamic histaminergic systems in the regulation of vigilance states in cats].1986
- Histamine Receptors in the Brain and Their Possible Functions1982
- A comparison between astemizole and other antihistamines on sleep-wakefulness cycles in dogsNeuropharmacology, 1981
- Sleep-inducing effects of three hypnotics in a new model of insomnia in ratsPharmacology Biochemistry and Behavior, 1981
- Inhibition of Histamine Synthesis in Brain by α‐Fluoromethylhistidine, a New Irreversible Inhibitor: In Vitro and In Vivo StudiesJournal of Neurochemistry, 1980
- Selective inhibitors of biosynthesis of aminergic neurotransmittersNature, 1978
- Dual localization of histamine in an ascending neuronal pathway and in non-neuronal cells evidenced by lesions in the lateral hypothalamic areaBrain Research, 1976